July 2026 – M A N O X B L O G

Théa Group to develop a new ophthalmic manufacturing facility in Gannat, France.

The new plant is expected to begin production in 2028 and manufacture more than 50 million sterile ophthalmic treatments annually, according to the companies. Théa Group, headquartered in Clermont-Ferrand, France,…

admin July 29, 2026

Biologic Drugs BioTech Medicines

The U.S. biotechnology sector is ceding dominance to China

China has been strategically growing its biotech sector for years, increasingly becoming a source of in-licensed or partnered drugs for Big Pharma. At the same time, the U.S. government has…

admin July 27, 2026

Cannabis

Sanitation of medical cannabis flowers (Cannabis sativa L., flos)

Sanitation of medical cannabis flowers (Cannabis sativa L., flos): comparing current technologies and non-thermal plasma novelties from safety and quality perspectives- Safety challenges associated with the use of cannabis In…

admin July 6, 2026

Pharmaceutical

EU looks to boost protective trade policy against Chinese pharmaceuticals and API imports

The EU is moving closer to strengthening EU stockpiles and production of key medicines under its Critical Medicines Act (CMA). The new rules, agreed by the European Parliament and ministers…

admin July 5, 2026

Cannabis

Modelo e obrigatoriedade de reporte trimestral de atividades de cultivo e fabrico de canábis para fins medicinais

Deliberação n.º 630/2026 O Conselho Diretivo do INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, I. P., considerando que: Compete ao INFARMED, I. P., regular e supervisionar todas…

admin July 2, 2026

Biologic Drugs BioTech Medicines

Biopharma strikes 50+ M&As deals in H1, led by Lilly’s $25B spend

The total of 52 mergers and acquisitions for the first half of 2026 reflects what analysts, industry watchers and executives are saying over and over: M&A is back. Nine deals…

admin July 2, 2026